Skip to content
Screener

Arrowhead Research ARWR Accounts Payable

Accounts Payable at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$47.7M+109%
Assembly Biosciences logo
Assembly BiosciencesASMB
$1.13M+29.0%
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
$1.46M-34.7%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$12.29M+59.6%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$10.78M+53.6%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$29.06M+5.6%

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$12.28B+445%
Enterprise value$12.2B+446%
P/S19.7×+15.8×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The source filing: Arrowhead Research’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0000879407-26-000047
Line itemMarch 31, 2026September 30, 2025
Total Assets$2,268,265$1,385,295
LIABILITIES, NONCONTROLLING INTEREST AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable30,747$17,674
Accrued expenses76,58590,419
Accrued payroll and benefits20,36626,895
Lease liabilities7,7747,289
Deferred revenue108,5432,399

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Arrowhead Research's accounts payable?
Arrowhead Research (ARWR) reported accounts payable of $30.75M in Q1 2026.
How has Arrowhead Research's accounts payable changed year-over-year?
Arrowhead Research's accounts payable increased by 208.1% year-over-year, from $9.98M to $30.75M.
What is the long-term trend for Arrowhead Research's accounts payable?
Over 4 years (2021 to 2025), Arrowhead Research's accounts payable has grown at a 16.9% compound annual growth rate (CAGR), from $9.46M to $17.67M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.

Ask your AI about Arrowhead Research's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude